These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6713867)

  • 1. Leukopenia and complement activation induced by different dialysis membranes.
    Man NK; Tien NQ; Lesavre P; Funck-Brentano JL
    Contrib Nephrol; 1984; 37():142-8. PubMed ID: 6713867
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodialysis leucopenia: the role of membrane type and re-use.
    Hoenich NA; Johnston SR; Woffindin C; Kerr DN
    Contrib Nephrol; 1984; 37():120-8. PubMed ID: 6713864
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxemia during hemodialysis: effect of different membranes and dialysate compositions.
    De Backer WA; Verpooten GA; Borgonjon DJ; Van Waeleghem JP; Vermeire PA; De Broe ME
    Contrib Nephrol; 1984; 37():134-41. PubMed ID: 6370588
    [No Abstract]   [Full Text] [Related]  

  • 9. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis leukopenia and complement function with different dialyzers.
    Amadori A; Candi P; Sasdelli M; Massai G; Favilla S; Passaleva A; Ricci M
    Kidney Int; 1983 Dec; 24(6):775-81. PubMed ID: 6562280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four dialyzer-dialysate combinations: effects on blood gases, cell counts, complement contact factors and fibrinolytic system.
    Vaziri ND; Barton CH; Warner A; Toohey J; Lintner C; Hung E; Mullin P; Samiminia B; O'Donnell M; Mallot K
    Contrib Nephrol; 1984; 37():111-9. PubMed ID: 6713863
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of hemodialysis.
    Eknoyan G
    N Engl J Med; 1984 Oct; 311(14):915-7. PubMed ID: 6472405
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
    Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
    Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.